Artivion ( AORT ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, August 7, 2025, at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
Artivion ( AORT ) Tops Q2 Earnings and Revenue Estimates
Artivion (AORT) delivered earnings and revenue surprises of +118.18% and +4.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Artivion ( AORT ) Q2 EPS Jumps 243%
Artivion ( NYSE:AORT ) , a leader in cardiac and vascular surgical devices, reported its Q2 2025 results on August 7, 2025. The company posted non-GAAP earnings per share of $0.24, outperforming the analyst estimate of approximately -$0.00 ( non-GAAP ) and marking a sharp increase from $0.07 per ...
Penumbra ( PEN ) Surpasses Q2 Earnings and Revenue Estimates
Penumbra (PEN) delivered earnings and revenue surprises of +6.17% and +3.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Artivion, Inc. Customers Whose Data May Have Been Compromised
NEWTOWN, Pa., July 13, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Artivion, Inc. ( "Artivion" ) . Artivion learned of a data breach on or about November 20, 2024. If you would like to discuss this case with ...
This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Artivion ( NYSE:AORT ) , Coinbase Global ( NASDAQ:COIN )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Canaccord Genuity analyst William Plovanic initiated coverage on Artivion, Inc.
Aortic Stent Graft Market Size is Expected to Reach $4.03 Billion by 2031, Driven by Aortic Aneurysms and Shift Toward Minimally Invasive Procedures | The Insight Partners
US & Canada, May 23, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the aortic stent graft market is witnessing significant growth owing to the rising prevalence of aortic aneurysms and the shift toward minimally invasive procedures.
Artivion ( AORT ) Lags Q1 Earnings Estimates
Artivion (AORT) delivered earnings and revenue surprises of -50% and 4.19%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Artivion ( AORT ) : Can Its 7.9% Jump Turn into More Strength?
Artivion (AORT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Do Options Traders Know Something About Artivion ( AORT ) Stock We Don't?
Investors need to pay close attention to Artivion (AORT) stock based on the movements in the options market lately.
Down -18.58% in 4 Weeks, Here's Why Artivion ( AORT ) Looks Ripe for a Turnaround
Artivion (AORT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Artivion ( AORT ) Reports Break-Even Earnings for Q4
Artivion (AORT) delivered earnings and revenue surprises of -100% and 3.56%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Sensus Healthcare ( SRTS ) Moves 19.9% Higher: Will This Strength Last?
Sensus Healthcare (SRTS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Thermo Fisher Scientific ( TMO ) Q4 Earnings and Revenues Top Estimates
Thermo Fisher (TMO) delivered earnings and revenue surprises of 2.87% and 1.31%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Best Momentum Stocks to Buy for January 7th
NN, VERX and AORT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 7, 2024.
New Strong Buy Stocks for January 7th
AORT, VERX, NN, IMCR and EVER have been added to the Zacks Rank #1 (Strong Buy) List on January 7, 2024.
Artivion ( AORT ) Tops Q3 Earnings and Revenue Estimates
Artivion (AORT) delivered earnings and revenue surprises of 300% and 0.66%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Ekso Bionics ( EKSO ) Reports Q3 Loss, Misses Revenue Estimates
Ekso Bionics (EKSO) delivered earnings and revenue surprises of -25% and 31.21%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Artivion ( AORT ) Surpasses Q2 Earnings and Revenue Estimates
Artivion (AORT) delivered earnings and revenue surprises of 133.33% and 0.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
ClearPoint Neuro, Inc. ( CLPT ) Reports Q2 Loss, Tops Revenue Estimates
ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of 15.79% and 4.84%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Inogen ( INGN ) Reports Q2 Loss, Tops Revenue Estimates
Inogen (INGN) delivered earnings and revenue surprises of 55.56% and 7.80%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Alphatec ( ATEC ) Reports Q2 Loss, Tops Revenue Estimates
Alphatec (ATEC) delivered earnings and revenue surprises of -11.54% and 0.40%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Global Artificial Blood Vessels Market to Surpass 3 Billion Mark by 2030 | DelveInsight
The artificial blood vessels market is anticipated to grow significantly in the coming years, driven by advancements in biotechnology and the rising prevalence of cardiovascular diseases.
Strength Seen in AxoGen ( AXGN ) : Can Its 5.4% Jump Turn into More Strength?
AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Artivion, Inc. ( AORT ) Hit a 52 Week High, Can the Run Continue?
Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday - Coca-Cola Consolidated ( NASDAQ:COKE ) , FibroGen ( NASDAQ:FGEN ) , Tempur Sealy Intl ( NYSE:TPX )
U.S. stocks were higher, with the Dow Jones gaining over 80 points on Tuesday. Shares of Tempur Sealy International, Inc. TPX rose sharply during Tuesday's session following upbeat quarterly earnings.
Artivion ( AORT ) Tops Q1 Earnings and Revenue Estimates
Artivion (AORT) delivered earnings and revenue surprises of 200% and 5.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Artivion ( AORT ) Outperforming Other Medical Stocks This Year?
Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year.
Stocks With Rising Relative Price Strength: TransMedics Group
TransMedics Group ( TMDX ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Monday, rising from 64 to 83. X IBD's unique RS Rating tracks market leadership by showing how a stock's price action over the last 52 weeks measures up against that of other stocks on the major ...
Artivion, Inc. ( AORT ) Hits Fresh High: Is There Still Room to Run?
Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Are Medical Stocks Lagging Artivion ( AORT ) This Year?
Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year.
3 Buy-Rated Small Caps Flexing Big Growth
Small-cap stocks can be solid considerations for those who can handle a higher level of volatility. Analysts have recently become bullish on these three.
Buy 5 Medical Devices Stocks for a Stable Portfolio in 2024
We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW.
Is Artivion ( AORT ) Stock Outpacing Its Medical Peers This Year?
Here is how Artivion (AORT) and Astria Therapeutics, Inc. (ATXS) have performed compared to their sector so far this year.
AxoGen, Inc. ( AXGN ) Hit a 52 Week High, Can the Run Continue?
AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is Artivion ( AORT ) Outperforming Other Medical Stocks This Year?
Here is how Artivion (AORT) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Artivion, Inc. ( AORT ) Hit a 52 Week High, Can the Run Continue?
Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Wall Street Analysts Think Artivion ( AORT ) Could Surge 30.7%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 30.7% in Artivion (AORT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday - Applied Mat ( NASDAQ:AMAT ) , Texas Roadhouse ( NASDAQ:TXRH ) , Vulcan Materials ( NYSE:VMC )
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday. Shares of Applied Materials, Inc. AMAT rose sharply in today's session after the company reported better-than-expected first-quarter financial results and issued second-quarter guidance.
Artivion ( AORT ) Surpasses Q4 Earnings and Revenue Estimates
Artivion (AORT) delivered earnings and revenue surprises of 184.62% and 4.37%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Artivion Reports Fourth Quarter and Full Year 2023 Financial Results
• Achieved revenue of in the fourth quarter of 2023 versus in the fourth quarter of 2022, an increase of 18% on a GAAP basis and 15% on a non-GAAP constant currency basis • Achieved revenue of for the full year of 2023 versus for the full year of 2022, an increase of 13% on a GAAP basis and 12% ...
Artivion Obtains $350 Million in Senior Secured Credit Facilities
Non-Dilutive Financing Provides Comprehensive Solution to Address Debt Maturities and Provide Flexibility to Further Optimize Capital Structure
Axogen Announces Promotions on Research and Development Team
Company Also Announces Departure of Angelo Scopelianos, Ph.D. Company Also Announces Departure of Angelo Scopelianos, Ph.D.
Axogen Announces Promotions on Research and Development Team - Axogen ( NASDAQ:AXGN )
ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 ( GLOBE NEWSWIRE ) -- Axogen, Inc. AXGN, a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the promotions of three research and development team members. The promotions are:
'Most Suspicious Congressional Stock Trade?' Little-Known Med Tech Firm Surges 48% In Just 2 Months After Senator Tina Smith Bought The Dip - Tactile Systems Tech ( NASDAQ:TCMD ) , Artivion ( NYSE:AORT )
Sen. Tina Smith's ( D-Minn. ) significant November investment in a medical device maker's stock has yielded a remarkable 48% return within just two months.
Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer
Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer. Announces Retirement of D ... PR ...
Forget Nancy Pelosi, This Democratic Senator Made Up To $55K Profit In Nearly 3 Weeks On This Medical Device Stock That's Lost 40% In Last 5 Years - Artivion ( NYSE:AORT )
Stock trading by the members of Congress is often looked upon with suspicion, given the possibility that they may have privy to insider information, and a Democratic senator's recent trades have come under the scanner. What Happened: Sen. Tina Smith ( D-MN ) bought shares in Georgia-based ...
Agilent Posts Upbeat Results, Joins Burlington Stores, Hibbett And Other Big Stocks Moving Higher On Tuesday - Agilent Technologies ( NYSE:A ) , Artivion ( NYSE:AORT )
U.S. stocks traded lower, with the Dow Jones falling around 90 points on Tuesday. Shares of Agilent Technologies, Inc. A jumped during Tuesday's session after the company reported better-than-expected fourth-quarter financial results.
A Congress Member Bought Up To $200K In Artivion Stock: Here's What You Need To Know - Artivion ( NYSE:AORT )
Tina Smith, a Senator, reported a purchase of Artivion AORT stock on November 20, 2023. According to the Periodic Transaction Report the transaction took place on November 20, 2023. What Happened: A recent report from the U.S.
Why Symbotic Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Acutus Medical ( NASDAQ:AFIB ) , AgileThought ( NASDAQ:AGIL )
Shares of Symbotic Inc. SYM surged in pre-market trading after the company reported better-than-expected fourth-quarter sales results. The company reported quarterly sales of $392.00 million which exceeded the analyst consensus estimate of $306.90 million.
